Health In Tech, Inc.
HIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | -6.86 | 0.04 | 0.00 |
| FCF Yield | 0.35% | 0.14% | -0.16% |
| EV / EBITDA | 182.71 | 73.14 | 1,335.63 |
| Quality | |||
| ROIC | 5.45% | 29.04% | 1.78% |
| Gross Margin | 79.21% | 87.97% | 94.21% |
| Cash Conversion Ratio | 3.25 | 0.39 | -3.22 |
| Growth | |||
| Revenue 3-Year CAGR | 50.05% | 2,675,375.30% | 1,793,475.97% |
| Free Cash Flow Growth | 231.70% | 188.07% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | -3.97 | -0.13 | -5.70 |
| Interest Coverage | 2.00 | 1,648.68 | 44.97 |
| Efficiency | |||
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -127.25 | -340.58 | -456.34 |